加拿大丰业银行美股招股说明书(2025-10-15版)

Filed Pursuant to Rule 424(b)(2)Registration No. 333-282565 The notes will not bear interest.The amount that you will be paid on your notes at maturity (expected to be the 2ndbusiness dayafter the valuation date) is based on the performance of the Health Care Select Sector SPDR®Fund (the reference asset) asmeasured from the trade date to and including the valuation date (expected to be approximately 15 to 17 months after the tradedate). If the final price on the valuation date is greater than the initial price (set on the trade date), the return on your notes will be positiveand will equal the participation rate of 150.00%timesthe reference asset return, which is the percentage increase or decrease in thefinal price from the initial price, subject to the maximum payment amount (expected to be between $1,196.35 and $1,230.25 for each$1,000 principal amount of your notes). If the final price on the valuation date is equal to the initial price, you will receive the principalamount of your notes.If the final price is less than the initial price, the return on your notes will be negative and you may loseup to your entire principal amount. Specifically, you will lose 1% for every 1% negative percentage change in the price ofthe reference asset below the initial price. Any payment on your notes is subject to the creditworthiness of The Bank ofNova Scotia. The return on your notes is linked to the performance of the reference asset, and not to the Health Care Select Sector Index(the reference asset index) on which the reference asset is based. To determine your payment at maturity, we will first calculate the reference asset return. At maturity, for each $1,000 principal amountof your notes: ●if the final price isgreater thanthe initial price (the reference asset return is positive), you will receive an amount in cash equal tothesumof (i) $1,000plus(ii) theproductof (a) $1,000times(b) the reference asset returntimes(c) the participation rate,subject to the maximum payment amount;●if the final price isequal tothe initial price (the reference asset return iszero), you will receive an amount in cash equal to$1,000;or●if the final price isless thanthe initial price (the reference asset return is negative), you will receive an amount in cash equal tothesumof (i) $1,000plus(ii) theproductof (a) $1,000times(b) the reference asset return.Following the determination of the initial price, the amount you will be paid on your notes at maturity will not be affected by the closing price of the reference asset on any day other than the valuation date.In addition, no payments on your notes will be made priorto maturity.Investment in the notes involves certain risks. You should refer to “Additional Risks” beginning on page P-15 of this pricing supplement and “Additional Risk Factors Specific to the Notes” beginning on page PS-6 of the accompanying productsupplement and “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement and on page 8 of theaccompanying prospectus.The initial estimated value of your notes at the time the terms of your notes are set on the trade date is expected to be between $944.10 and $974.10 per $1,000 principal amount, which will be less than the original issue price of your noteslisted below.See “Additional Information Regarding Estimated Value of the Notes” on the following page and “Additional Risks”beginning on page P-15 of this document for additional information. The actual value of your notes at any time will reflect manyfactors and cannot be predicted with accuracy.1 1For additional information, see “Supplemental Plan of Distribution (Conflicts of Interest)” herein. Neither the United States Securities and Exchange Commission (the “SEC”) nor any state securities commission hasapproved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement, theaccompanyingprospectus,prospectus supplement,underlier supplement or product supplement.Anyrepresentation to the contrary is a criminal offense. The notes are not insured by the Canada Deposit Insurance Corporation (the “CDIC”) pursuant to the Canada DepositInsuranceCorporation Act(the“CDIC Act”)or the U.S.Federal Deposit Insurance Corporation or any othergovernment agency of Canada, the United States or any other jurisdiction. Scotia Capital (USA) Inc.Pricing Supplementdated, 2025 The Capped Enhanced Participation Notes Linked to the shares of the Health Care Select Sector SPDR®Fund Due [•] (the“notes”) offered hereunder are unsubordinated and unsecured obligations of The Bank of Nova Scotia (the “Bank”) and aresubject to investment risks including possible loss of the principal amount invested due to the negative performance of thereference asset and the credit risk of the Bank. As used in this pricing supplement, the “Bank,” “we,” “us” or “our” refers to TheBank of Nova Scotia. The notes will not be listed on any U.S. securities exchange or automated quotation system. The return